[Melanomas and basal cell carcinomas in a patient with Parkinson disease].
Hiraldo
A
A
Gómez-Moyano
E
E
Martínez
S
S
Sanz
A
A
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000150:complications* / Q000601:surgery; D004198:Disease Susceptibility; D004298:Dopamine / Q000096:biosynthesis; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008543:Melanins / Q000096:biosynthesis; D008545:Melanoma / Q000150:complications* / Q000601:surgery; D009378:Neoplasms, Multiple Primary / Q000150:complications*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D012878:Skin Neoplasms / Q000150:complications* / Q000601:surgery
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D008543:Melanins; D007980:Levodopa; D004298:Dopamine